StonvexLoading…
StonvexStonvexStonvexCore line items from TCBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $53.45M | $51.33M | $50.09M |
Operating Income | $166.16M | $155.10M | $160.91M |
Net Income | $121.56M | $114.87M | $117.39M |
EPS (Diluted) | $3.70 | $3.46 | $3.52 |
Total Assets | $9.82B | $9.67B | $9.91B |
Total Liabilities | $8.49B | $8.45B | $8.75B |
Cash & Equivalents | $157.01M | $144.96M | $98.70M |
Free Cash Flow OCF − CapEx | $127.93M | $105.15M | $134.00M |
Shares Outstanding | 32.33M | 32.97M | 33.27M |